Press Release Archive
Press Releases
October 2023
10.12.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
June 2023
06.23.2023
Prescription Medicines Medicines FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
06.20.2023
Prescription Medicines Medicines Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval
April 2023
04.29.2023
04.04.2023
March 2023
03.16.2023
03.16.2023
03.10.2023
February 2023
02.22.2023
02.16.2023
02.16.2023
02.10.2023
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.